Taylor Boyd
Abzena has appointed Taylor Boyd as Chief Business Officer
Read More
Author: Emily Kimber
ICR researchers develop blood test to uncover how childhood tumours adapt
It is hoped that the approach will lead to more targeted treatments for childhood cancers
Read More
Mukhtar Ahmed
BC Platforms has appointed Mukhtar Ahmed as CEO
Read More
FDA approves Deciphera’s Romvimza for rare tumour type
Tenosynovial giant cell tumours can cause pain, stiffness, swelling and movement limitations
Read More
Stephan Fritschi
Carbogen Amcis has appointed Stephan Fritschi as CEO
Read More- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
